Prestige Consumer Healthcare Stock Forecast, Price & News

Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions

Is Prestige Consumer Healthcare a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Prestige Consumer Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PBH, but not buy additional shares or sell existing shares.
View analyst ratings for Prestige Consumer Healthcare or view top-rated stocks.

What stocks does MarketBeat like better than Prestige Consumer Healthcare?

Wall Street analysts have given Prestige Consumer Healthcare a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Prestige Consumer Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Prestige Consumer Healthcare's next earnings date?

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Prestige Consumer Healthcare.

How can I listen to Prestige Consumer Healthcare's earnings call?

Prestige Consumer Healthcare will be holding an earnings conference call on Thursday, November 4th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 404-537-3406 with passcode "7261575".

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) issued its quarterly earnings data on Thursday, August, 5th. The company reported $1.14 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.87 by $0.27. The business had revenue of $269.10 million for the quarter, compared to analyst estimates of $232.41 million. Prestige Consumer Healthcare had a net margin of 18.18% and a trailing twelve-month return on equity of 13.25%. The company's quarterly revenue was up 17.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.86 earnings per share.
View Prestige Consumer Healthcare's earnings history.

How has Prestige Consumer Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PBH shares have increased by 66.3% and is now trading at $59.73.
View which stocks have been most impacted by COVID-19.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare updated its FY 2022 earnings guidance on Thursday, September, 2nd. The company provided earnings per share (EPS) guidance of $3.900-$ for the period, compared to the Thomson Reuters consensus EPS estimate of $3.610. The company issued revenue guidance of $1.05 B-, compared to the consensus revenue estimate of $969.54 million.

What price target have analysts set for PBH?

5 brokerages have issued 1 year target prices for Prestige Consumer Healthcare's shares. Their forecasts range from $61.00 to $125.00. On average, they anticipate Prestige Consumer Healthcare's stock price to reach $107.40 in the next year. This suggests a possible upside of 79.8% from the stock's current price.
View analysts' price targets for Prestige Consumer Healthcare or view top-rated stocks among Wall Street analysts.

Who are Prestige Consumer Healthcare's key executives?

Prestige Consumer Healthcare's management team includes the following people:

• Ronald M. Lombardi, Chairman, President & Chief Executive Officer
• Jeff Zerillo, Senior Vice President-Operations
• Christine Sacco, Chief Financial Officer
• William C. P'Pool, Secretary, Senior Vice President & General Counsel
• Adel Mekhail, Executive Vice President-Marketing & Sales

What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO?

8 employees have rated Prestige Consumer Healthcare CEO Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among Prestige Consumer Healthcare's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Prestige Consumer Healthcare's key competitors?

Some companies that are related to Prestige Consumer Healthcare include The Estée Lauder Companies (EL), Herbalife Nutrition (HLF), Inter Parfums (IPAR), Medifast (MED), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Veru (VERU), Revlon (REV) and Nature's Sunshine Products (NATR).
View all of PBH's competitors.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA).

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include North Star Asset Management Inc. (0.50%), Wedge Capital Management L L P NC (0.39%), Foundry Partners LLC (0.34%), Robeco Institutional Asset Management B.V. (0.31%), Hillsdale Investment Management Inc. (0.18%) and New York State Teachers Retirement System (0.13%). Company insiders that own Prestige Consumer Healthcare stock include Mary Beth Fritz, Paton Brett and Ronald M Lombardi.
View institutional ownership trends for Prestige Consumer Healthcare.

Which institutional investors are selling Prestige Consumer Healthcare stock?

PBH stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC, Wedge Capital Management L L P NC, Exchange Traded Concepts LLC, CHICAGO TRUST Co NA, and Crossmark Global Holdings Inc..
View insider buying and selling activity for Prestige Consumer Healthcare or view top insider-selling stocks.

Which institutional investors are buying Prestige Consumer Healthcare stock?

PBH stock was bought by a variety of institutional investors in the last quarter, including Foundry Partners LLC, Robeco Institutional Asset Management B.V., Strs Ohio, Hillsdale Investment Management Inc., Everence Capital Management Inc., Ritholtz Wealth Management, State of Alaska Department of Revenue, and North Star Asset Management Inc..
View insider buying and selling activity for Prestige Consumer Healthcare or or view top insider-buying stocks.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $59.73.

How much money does Prestige Consumer Healthcare make?

Prestige Consumer Healthcare has a market capitalization of $2.99 billion and generates $943.36 million in revenue each year. The company earns $164.68 million in net income (profit) each year or $3.24 on an earnings per share basis.

How many employees does Prestige Consumer Healthcare have?

Prestige Consumer Healthcare employs 505 workers across the globe.

What is Prestige Consumer Healthcare's official website?

The official website for Prestige Consumer Healthcare is www.prestigebrands.com.

Where are Prestige Consumer Healthcare's headquarters?

Prestige Consumer Healthcare is headquartered at 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at (914) 524-6800 or via email at [email protected].